Under Contract
Biotech/Peptides Manufacturing Company
Peptide Manufacturing and Distribution Company in Central Region USA
On NextCompany since September 5, 2026 (40 days)
Location undisclosed
Business overview
This Central Region USA company manufactures and distributes peptides for health and wellness. It serves B2B and B2C customers online in the United States and Mexico. Its operations integrate back-office functions and logistics.
The transaction is under contract through The Gottesman Company. The owner seeks to sell majority control while retaining a partial equity stake. The business reports 2026 revenue of $11.0M and EBITDA of $2.8M.
Who is a good fit for this business
- Buyers who can fund marketing and expansion into existing and new geographies.
- Acquirers seeking majority control with the owner retaining a partial equity stake.
Details
- Reason for selling
- Owner is looking to sell majority control and retain a partial equity stake.
Frequently Asked Questions
The company manufactures and distributes peptides for health and wellness. It sells online through B2B and B2C channels. Its products reach markets in the United States and Mexico.
The business reports revenue of $11.0M for 2026 versus $4.7M for 2025. It reports EBITDA of $2.8M for 2026 versus $1.1M for 2025.
The owner seeks a majority-control sale and plans to retain a partial equity stake. An existing management team runs the business.
The company plans to expand worldwide beyond its existing markets. It seeks a buyer to fund marketing and supply capital for geographic growth.